Screener
Aflac AFL Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$4.1BBeat by $10.4M
Adjusted EPS$1.75Miss by $0.01
Revenue estimate$4.1B
EPS estimate$1.76
“Aflac delivered solid earnings for the quarter and for the first six months. These results reflect execution of our strategy, driving long-term value for shareholders. In Japan, we have secured new opportunities through successful product initiatives including Anshin Palette (medical insurance), Miraito (cancer insurance) and Tsumitasu (life insurance). In the U.S., our focus is on meeting the evolving needs of employers and their employees with supplemental health products and related benefits.”
Next report
Nov 4, 2026 (in a month)Revenue estimate$4.1B
EPS estimate$1.81
Financials
Q2 2026Valuation & ratios
Segments
By segment
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Aflac report Q2 2026 earnings?
- Aflac (AFL) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were Aflac's Q2 2026 revenue and EPS?
- Aflac reported revenue of $4.1B and adjusted eps of $1.75 for Q2 2026.
- Did Aflac beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $4.1B by $10.4M. EPS missed the consensus estimate of $1.76 by $0.01.
- How did Aflac's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 2.4% from $4.2B a year earlier.
- Where can I find Aflac's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-054333) and the 10-Q periodic report (0001628280-26-054618) directly on SEC EDGAR. The filing index links above go to sec.gov.
